GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Other Operating Expense

Pet Pharm Biotech Co (ROCO:7762) Other Operating Expense : NT$-0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co Other Operating Expense?

Pet Pharm Biotech Co's Other Operating Expense for the six months ended in Dec. 2024 was NT$-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.0 Mil.

Pet Pharm Biotech Co's quarterly Other Operating Expense declined from Dec. 2023 (NT$0.0 Mil) to Jun. 2024 (NT$0.0 Mil) and declined from Jun. 2024 (NT$0.0 Mil) to Dec. 2024 (NT$-0.0 Mil).

Pet Pharm Biotech Co's annual Other Operating Expense stayed the same from Dec. 2022 (NT$0.0 Mil) to Dec. 2023 (NT$0.0 Mil) but then increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$0.0 Mil).

Pet Pharm Biotech Co Other Operating Expense Historical Data

The historical data trend for Pet Pharm Biotech Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co Other Operating Expense Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24
Other Operating Expense
- - -

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Other Operating Expense - - - - -

Pet Pharm Biotech Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pet Pharm Biotech Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pet Pharm Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Other Operating Expense
Comparable Companies
ROCO:6130 ROCO:4102 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN GILD PFE XPAR:SAN BMY TSE:4519 LSE:GSK TSE:4568 SHSE:600276 XTER:BAYN
Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Website
https://www.petpharmbio.com
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines